How to administer Adequan® Canine to proactively treat canine
osteoarthritis (OA) disease, not just the clinical signs.1
At early signs of OA or degenerative joint disease (DJD), veterinarians can prescribe Adequan® Canine (polysulfated glycosaminoglycan) at the
approved dose to help slow the disease progression with the expectation of achieving the same results shown in clinical studies.1,2
After the initial series, veterinarians and owners should work together to keep monitoring the dog’s joint health and mobility.
Repeat the dosing regimen as needed upon recurrence of clinical signs.